Capiton AG is exploring a potential listing or sale of KD Pharma Group, a maker of Omega-3 fish oils for pharmaceutical and nutrition industries, according to people familiar with the matter.
The German private equity firm could seek as much as 1 billion euros ($1.1 billion) in a deal slated for later this year, said the people, who asked not to be identified discussing confidential information. Capiton is working with Jefferies Financial Group Inc., UBS Group AG and Evercore Inc., they said.
